BUY Biocon Ltd — IDBI Capital
byIDBI CapitalHorizon: 1–3 months23 Jun 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Biocon Ltd completed the acquisition of 1,15,36,956 equity shares of its material subsidiary, Biocon Biologics Limited (BBL), from 127 selling shareholders. In consideration, Biocon allotted 87,86,362
BSE · Company Update·29 Jun · today
1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·19 Jun · 1w ago
Biocon Limited has acquired an equity stake in Ampin C&I Power Twelve Private Limited, a Special Purpose Vehicle formed for generation and supply of solar power. This acquisition aligns with Biocon's
NSE · Acquisition·10 Jun · 3w ago
3 advisors have active long-term BUY calls on this stock
Advisor consensus · adjacent horizon·20 May · 1mo ago
Nothing found in this tip’s window yet.
2 advisors have active long-term SELL calls on this stock
Advisor consensus · adjacent horizon·14 Nov · 8mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.